Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Nephros, Inc.

NEPHNASDAQ
Healthcare
Medical - Instruments & Supplies
$3.89
$-0.19(-4.66%)
U.S. Market opens in 9h 46m

Nephros, Inc. (NEPH) Stock Overview

Explore Nephros, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap40.1M
P/E Ratio28.06
EPS (TTM)$0.14
ROE0.16%
Fundamental Analysis

AI Price Forecasts

1 Month$4.08
3 Months$5.40
1 Year Target$7.00

NEPH Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Nephros, Inc. (NEPH) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 41.09, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $7.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 28.06 and a market capitalization of 40.1M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-7.60%
5-Day Change
-7.14%
1-Month Change
-19.44%
3-Month Change
-22.59%
6-Month Change
-9.81%
Year-to-Date (YTD) Change
-20.63%
1-Year Change
140.13%
3-Year Change
239.64%
5-Year Change
-51.54%
All-Time (Max) Change
-99.64%

Contact Information

201 343 5202
380 Lackawanna Place, South Orange, NJ, 07079

Company Facts

310 Employees
IPO DateSep 21, 2004
CountryUS
Actively Trading

Frequently Asked Questions